Dun & Bradstreet (DNB) Misses Q3 EPS by 1c

Dun & Bradstreet (NYSE: DNB) reported Q3 EPS of $0.29, $0.01 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $556.3 million versus the consensus estimate of $558.61 million.

GUIDANCE:

Dun & Bradstreet sees FY2022 EPS of $1.10-$1.14, versus the consensus of $1.12. Dun & Bradstreet sees FY2022 revenue of $2.215-2.235 billion, versus the consensus of $2.24 billion.

For earnings history and earnings-related data on Dun & Bradstreet (DNB) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• RCM Technologies (RCMT) Tops Q2 EPS by 17c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c